Psychobiotics are a type of probiotic that has been shown to improve people's mental health. Their ability to produce or encourage the creation of neurotransmitters, short-chain fatty acids, enteroendocrine hormones, and anti-inflammatory cytokines sets them apart from traditional probiotics. Psychobiotics have a wide range of applications due to this potential, ranging from mood and stress relief to being used as an adjuvant in the treatment of various neurodevelopment and neurodegenerative disorders. Psychobiotics is a word used in preliminary research to refer to live bacteria that, when taken in proper numbers, may have a positive effect on the host organism's microbiome, potentially improving mental health. The processes by which microorganisms exert their psychobiotic potential are still to be fully understood. However, it has been discovered that these bacteria benefit mostly through the hypothalamic-pituitary-adrenal (HPA) axis, immunological response and inflammation, and neurohormone and neurotransmitter synthesis.
Title : Results from a cross-sectional observational study examining irritable bowel syndrome patients six months after finishing their participation in the ViIBS trial
Jacek Piatek, Calisia University, Poland
Title : Gut microbiome as a driver of healthy ageing
Thi Thu Hao Van, RMIT University, Australia
Title : Treating irritable bowel syndrome patients with a balanced multi-strain synbiotic–results from a multi-center, randomized, double-blind, placebo-controlled clinical trial (the ViIBS trial)
Henning Sommermeyer, Calisia University, Poland
Title : Molecular mechanisms underlying the anti-atherogenic actions of probiotics
Dipak P Ramji, Cardiff University, United Kingdom
Title : Global regulatory trends on the use of probiotics and prebiotics in foods and food supplements
David Pineda Ereno, DPE International Consulting, Belgium
Title : Biochemical profile and nutripotential glimpses of Terminalia arjuna bark extract
Suriyavathana Muthukrishnan, Periyar University, India